Allergy Research
·May 27, 2019
First approved treatment for peanut allergy may be marketed this…
Aimmune Therapeutics, the US company developing the peanut allergy therapy dubbed ‘AR101’, is set to receive a US FDA decision regarding its marketing application for the product in September this year. The drug is designed as a once-daily peanut allergen…